Beyond Medications: Modern Epilepsy Surgery Offers New Hope
November is National Epilepsy Awareness Month, a time to highlight advances in epilepsy treatment. Epilepsy affects approximately 3.4 million Americans, and nearly one-third continue experiencing seizures despite medications.
An important message remains overlooked: Epilepsy surgery is no longer a treatment of last resort. Patients who continue having seizures despite trying two appropriately selected antiseizure medications should be referred for a comprehensive epilepsy evaluation.
Today, remarkable advances in neuroscience offer several surgical options.
- Resective Surgery: Removes seizure-producing brain tissue and may offer long-term seizure freedom.
- Laser Ablation (LITT): Uses MRI-guided laser technology to precisely destroy seizure-generating tissue through a minimally invasive procedure.
- Stereo-EEG (SEEG-RFTC) or RFA: Precisely placed electrodes identify where seizures originate and destroy seizure producing brain tissue with radiofrequency Ablation.
- Vagus Nerve Stimulation (VNS): An implanted device delivers electrical impulses to help reduce seizures.
- Responsive Neurostimulation (RNS): A smart implanted device detects abnormal brain activity and responds with targeted electrical stimulation.
- Deep Brain Stimulation (DBS): Electrodes implanted in specific brain regions help regulate seizure networks.
Advanced Epilepsy Care in Huntington
Marshall Health Network’s Epilepsy and Seizure Center at Cabell Huntington Hospital is recognized by the National Association of Epilepsy Centers as a level 3 center. It is the region’s first center staffed by epilepsy specialists and dedicated to the diagnosis, care and treatment of adults, adolescents and children suffering from a wide range of neurological disorders and conditions. Its services include specialized evaluation, video EEG monitoring and individualized treatment planning.
Working alongside Heather Pinckard-Dover, MD, director of stereotactic and functional neurosurgery at Marshall Health Network and associate professor of neurosurgery at Marshall University Joan C. Edwards School of Medicine, our multidisciplinary team brings advanced epilepsy care closer to patients across the Tri-State region.
Epilepsy surgery may not be suitable for everyone, but for selected patients, it can significantly reduce seizures, restore independence and sometimes achieve seizure freedom.
This November, remember: If two medications failed, ask about an epilepsy surgery evaluation. Sometimes the next breakthrough isn’t another medication. It’s surgery.
Dr. Samrina Hanif is a board-certified, fellowship-trained neurologist at Marshall Health Network, director of the epilepsy program at Cabell Huntington Hospital and an associate professor of neurology at the Marshall University Joan C. Edwards School of Medicine.
This content was also published Nov. 14, 2026 by HD Media.